Advertisement

Ads Placeholder
Loading...

BioNTech SE

BNTX•NASDAQ
Healthcare
Biotechnology
$91.18
$1.76(1.97%)
U.S. Market opens in 29h 1m

BioNTech SE (BNTX) Stock Overview

Explore BioNTech SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap22.9B
P/E Ratio-17.12
EPS (TTM)$-5.44
ROE-0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$73.64
3 Months$99.79
1 Year Target$76.95

BNTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioNTech SE (BNTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $76.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.12 and a market capitalization of 22.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.97%
5-Day Change
4.06%
1-Month Change
-9.51%
3-Month Change
-5.70%
6-Month Change
-13.57%
Year-to-Date (YTD) Change
-5.70%
1-Year Change
-0.90%
3-Year Change
-29.61%
5-Year Change
-20.97%
All-Time (Max) Change
540.31%

Contact Information

https://www.biontech.de
49 6131 9084 0
An der Goldgrube 12, Mainz, NaN, 55131

Company Facts

67,720 Employees
IPO DateOct 10, 2019
CountryDE
Actively Trading

Frequently Asked Questions